Kreahling JM - Search Results

1

Wee1 inhibition by MK-1775 leads to tumor inhibition and enhances efficacy of gemcitabine in human sarcomas.

Kreahling JM, Foroutan P, Reed D, Martinez G, Razabdouski T, Bui MM, Raghavan M, Letson D, Gillies RJ, Altiok S. Kreahling JM, et al. PLoS One. 2013;8(3):e57523. doi: 10.1371/journal.pone.0057523. Epub 2013 Mar 8. PLoS One. 2013. PMID: 23520471 Free PMC article. Clinical Trial.

2

MK1775, a selective Wee1 inhibitor, shows single-agent antitumor activity against sarcoma cells.

Kreahling JM, Gemmer JY, Reed D, Letson D, Bui M, Altiok S. Kreahling JM, et al. Mol Cancer Ther. 2012 Jan;11(1):174-82. doi: 10.1158/1535-7163.MCT-11-0529. Epub 2011 Nov 14. Mol Cancer Ther. 2012. PMID: 22084170 Free PMC article.

3

Diffusion MRI and novel texture analysis in osteosarcoma xenotransplants predicts response to anti-checkpoint therapy.

Foroutan P, Kreahling JM, Morse DL, Grove O, Lloyd MC, Reed D, Raghavan M, Altiok S, Martinez GV, Gillies RJ. Foroutan P, et al. Among authors: kreahling jm. PLoS One. 2013 Dec 16;8(12):e82875. doi: 10.1371/journal.pone.0082875. eCollection 2013. PLoS One. 2013. PMID: 24358232 Free PMC article.

4

Identification of Synergistic, Clinically Achievable, Combination Therapies for Osteosarcoma.

Yu D, Kahen E, Cubitt CL, McGuire J, Kreahling J, Lee J, Altiok S, Lynch CC, Sullivan DM, Reed DR. Yu D, et al. Sci Rep. 2015 Nov 25;5:16991. doi: 10.1038/srep16991. Sci Rep. 2015. PMID: 26601688 Free PMC article.

5

Microfluidic Biopsy Trapping Device for the Real-Time Monitoring of Tumor Microenvironment.

Holton AB, Sinatra FL, Kreahling J, Conway AJ, Landis DA, Altiok S. Holton AB, et al. PLoS One. 2017 Jan 13;12(1):e0169797. doi: 10.1371/journal.pone.0169797. eCollection 2017. PLoS One. 2017. PMID: 28085924 Free PMC article.

6

Histone deacetylase inhibitors downregulate checkpoint kinase 1 expression to induce cell death in non-small cell lung cancer cells.

Brazelle W, Kreahling JM, Gemmer J, Ma Y, Cress WD, Haura E, Altiok S. Brazelle W, et al. Among authors: kreahling jm. PLoS One. 2010 Dec 14;5(12):e14335. doi: 10.1371/journal.pone.0014335. PLoS One. 2010. PMID: 21179472 Free PMC article.

7

Special Technologies for Ex Vivo Analysis of Cancer.

Kreahling JM, Altiok S. Kreahling JM, et al. Cancer Control. 2015 Apr;22(2):226-31. doi: 10.1177/107327481502200215. Cancer Control. 2015. PMID: 26068769 Free article. Review.

8

A phase I, pharmacokinetic, and pharmacodynamic study of panobinostat, an HDAC inhibitor, combined with erlotinib in patients with advanced aerodigestive tract tumors.

Gray JE, Haura E, Chiappori A, Tanvetyanon T, Williams CC, Pinder-Schenck M, Kish JA, Kreahling J, Lush R, Neuger A, Tetteh L, Akar A, Zhao X, Schell MJ, Bepler G, Altiok S. Gray JE, et al. Clin Cancer Res. 2014 Mar 15;20(6):1644-55. doi: 10.1158/1078-0432.CCR-13-2235. Epub 2014 Jan 15. Clin Cancer Res. 2014. PMID: 24429877 Free PMC article. Clinical Trial.

9

Gene silencing of SLC5A8 identified by genome-wide methylation profiling in lung cancer.

Park JY, Kim D, Yang M, Park HY, Lee SH, Rincon M, Kreahling J, Plass C, Smiraglia DJ, Tockman MS, Kim SJ. Park JY, et al. Lung Cancer. 2013 Mar;79(3):198-204. doi: 10.1016/j.lungcan.2012.11.019. Epub 2012 Dec 27. Lung Cancer. 2013. PMID: 23273563 Free PMC article.

10

The iStem, a long-range RNA secondary structure element required for efficient exon inclusion in the Drosophila Dscam pre-mRNA.

Kreahling JM, Graveley BR. Kreahling JM, et al. Mol Cell Biol. 2005 Dec;25(23):10251-60. doi: 10.1128/MCB.25.23.10251-10260.2005. Mol Cell Biol. 2005. PMID: 16287842 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11 results

Search Page

Filters